Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Cari Gallman is EVP, General Counsel at Bristol Myers Squibb. OQRO lists 20 transactions filed with the SEC under this name, the latest on Oct 5, 2026, each linked to the official Form 4.
EVP, General Counsel
Disclosures on record
20
Companies involved
1
As of the latest filing on , Cari Gallman reported holding 15,876 shares of Bristol Myers Squibb (BMY), worth about $946K at the last close of $60 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bristol Myers Squibb BMY | 15,876 | 16K direct | $60 | $946K | Oct 2, 2026 |
Is this Cari Gallman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Bristol Myers SquibbBMY
20 disclosures · Mar 2026 – Oct 2026
Oct 2, 20264,559disclosed Oct 5
DetailsOfficial recordOct 2, 20264,559disclosed Oct 5
DetailsOfficial recordOct 2, 20262,332disclosed Oct 5
DetailsOfficial recordAug 1, 20261,061disclosed Aug 4
DetailsOfficial recordAug 1, 20261,061disclosed Aug 4
DetailsOfficial recordAug 1, 2026543disclosed Aug 4
DetailsOfficial recordMar 10, 202639Kdisclosed Mar 12
DetailsOfficial recordMar 10, 202626Kdisclosed Mar 12
DetailsOfficial recordMar 10, 2026867disclosed Mar 12
DetailsOfficial recordMar 10, 2026867disclosed Mar 12
DetailsOfficial recordMar 10, 2026912disclosed Mar 12
DetailsOfficial recordMar 10, 2026912disclosed Mar 12
DetailsOfficial recordMar 10, 20265,201disclosed Mar 12
DetailsOfficial recordMar 10, 20265,201disclosed Mar 12
DetailsOfficial recordMar 10, 20262,554disclosed Mar 12
DetailsOfficial recordMar 10, 202694disclosed Mar 12
DetailsOfficial recordMar 10, 2026102disclosed Mar 12
DetailsOfficial recordMar 10, 20261,354disclosed Mar 12
DetailsOfficial recordMar 10, 2026396disclosed Mar 12
DetailsOfficial recordMar 10, 2026415disclosed Mar 12
DetailsOfficial recordOn the latest SEC Form 4, dated Oct 2, 2026, Cari Gallman reported holding 15,876 shares of Bristol Myers Squibb (BMY). At the last close of $60 on Nov 18, 2026, that is about $946K. This is the stake disclosed in filings, not a net worth.
No public filing gives Cari Gallman's net worth. What SEC Form 4 shows is the stock stake: 15,876 shares of Bristol Myers Squibb (BMY), about $946K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.